BMRA (BIOMERICA INC) Stock Analysis - SEC Filings

BIOMERICA INC (BMRA) is a publicly traded Healthcare sector company. As of May 21, 2026, BMRA trades at $2.35 with a market cap of $6.95M and a P/E ratio of -0.93. BMRA moved +0.00% today. Year to date, BMRA is -9.62%; over the trailing twelve months it is -35.44%. Its 52-week range spans $1.87 to $10.16. Rallies surfaces BMRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find BMRA SEC filings?

Rallies organizes BMRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

BMRA Key Metrics

Key financial metrics for BMRA
MetricValue
Price$2.35
Market Cap$6.95M
P/E Ratio-0.93
EPS$-2.49
Dividend Yield0.00%
52-Week High$10.16
52-Week Low$1.87
Volume0
Avg Volume0
Revenue (TTM)$4.46M
Net Income$-4.03M
Gross Margin5.61%

Latest BMRA News

Recent BMRA Insider Trades

  • Irani Zackary S. bought 200 (~$310) on May 25, 2023.
  • Irani Zackary S. bought 500 (~$805) on May 24, 2023.
  • Irani Zackary S. bought 1.70K (~$1.99K) on May 12, 2023.

BMRA Analyst Consensus

BMRA analyst coverage data. Average price target: $0.00.

Common questions about BMRA

Where can I find BMRA SEC filings?
Rallies organizes BMRA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show BMRA 10-K and 10-Q filings?
Rallies organizes BMRA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is BMRA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMRA. It does not provide personalized investment advice.
BMRA

BMRA